Key result
Albuterol during asthma exacerbation linked to Takotsubo cardiomyopathy via beta-agonist stress.
Why the study?
The association between beta agonists and takotsubo cardiomyopathy in asthmatic patients is not well understood.
Case Report (n=1)
Beta agonists such as albuterol should be recognized as a potential stressor capable of inducing Takotsubo cardiomyopathy in asthmatic patients.
May warrant vigilance for Takotsubo with albuterol in asthma; leaves open a causal role for beta-agonists.
Takotsubo cardiomyopathy (TCM) is an entity of reversible cardiomyopathy known for its association with physical or emotional stress and may mimic myocardial infarction. We report an exceedingly rare case of albuterol-induced TCM with moderate asthma exacerbation. An interesting association that may help in understanding the etiology of TCM in the asthmatic population. Although the prognosis of TCM is excellent, it is crucial to recognize beta agonists as a potential stressor.
No takes yet. Share an insight, caveat, or question.
Marmoush et al. (2015) conducted a case report in Takotsubo cardiomyopathy and asthma (n=1). Albuterol was evaluated on Development of Takotsubo cardiomyopathy. Albuterol administration during a moderate asthma exacerbation induced Takotsubo cardiomyopathy, indicating beta agonists as a potential stressor.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: